Witnesses
Tuesday 27 November 2012
Stephen Whitehead, Chief Executive, Association of the British Pharmaceutical Industry, Laura Weir, Chair, Patients Involved in NICE, Dr Linda Patterson OBE, Clinical Vice-President, Royal College of Physicians of London, and Professor Peter Johnson, Chief Clinician, Cancer Research UK.
| |
Tuesday 4 December 2012
| |
Professor Peter Smith, Senior Associate, Nuffield Trust, Professor Peter Littlejohns, King's College London, and Professor Albert Weale, University College London.
| |
Sir Michael Rawlins, Chair, and Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence (NICE).
| |
| |
| |
|
|